| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.19B | — | -5.2% |
| R&D Expense | $10.0M | — | -16.7% |
| SG&A Expense | $83.0M | — | +16.9% |
| Interest Expense | $35.0M | — | -34.0% |
| Pre-tax Income | $499.0M | — | -25.3% |
| Income Tax | $82.0M | — | -31.7% |
| Net Income | $425.0M | — | -22.4% |
| EPS (Basic) | $1.61 | — | -22.6% |
| EPS (Diluted) | $1.60 | — | -22.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.35B | -15.3% | +12.6% |
| Accounts Receivable | $1.19B | +12.0% | -0.9% |
| Inventory | $2.30B | +5.5% | +5.3% |
| Current Assets | $5.68B | +3.8% | +9.0% |
| Total Assets | $16.64B | +3.2% | +14.2% |
| Current Liabilities | $3.83B | +0.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$179.0M | — | -338.7% |
| Capital Expenditures | $119.0M | — | +28.0% |
| Investing Cash Flow | -$129.0M | — | -19.4% |
| Financing Cash Flow | $60.0M | — | -22.1% |
| Free Cash Flow | -$298.0M | — | -1555.6% |
| +25.9% |
| Long-term Debt | $2.44B | +0.1% | -5.1% |
| Total Liabilities | $9.75B | -1.9% | +12.6% |
| Stockholders' Equity | $6.83B | +11.6% | +17.4% |